| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |